HP Inc vs Nuwellis Inc — how do they compare? HP Inc trades at $29.19 (market cap $26.59B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: HP Inc is far larger — about 48986.7× Nuwellis Inc's market cap, and HP Inc pays a 4.13% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| HPQ | NUWE | |
|---|---|---|
Market Cap | $26.59B | $542.80K |
Sector | Technology | Technology |
52-Week High | $30.05 | $220.50 |
52-Week Low | $18.20 | $1.42 |
Enterprise Value | $33.75B | -$1.27M |
Dividend Yield | 4.13% | — |
Signals from Pluang's Aura AI — not financial advice
HPQ trades at $29.80, down 0.83% on the day, with a bullish technical signal supported by moving averages and positive earnings beats in recent quarters. The company reported Q2 2026 revenue of $14.4B and EPS of $0.86, exceeding expectations, driven by premium product mix and AI-driven efficiencies. Valuation metrics show a P/E of 10.77 and P/S of 0.48, indicating potential undervaluation relative to historical averages.
The outlook remains positive with continued earnings momentum and a 2026 revenue forecast of $57.4B, though risks include PC market volatility and competitive pressures. Analyst consensus is mixed with 29% buy ratings, but technical support at $29 suggests near-term stability. The dividend yield of approximately 4% provides income appeal amid growth initiatives.
No Aura AI signal available yet.
Trailing returns across standard periods
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →